Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Ginkgo Bioworks Stock Quote

Ginkgo Bioworks (NYSE: DNA)

Price as of May 29, 2024, 4:00 p.m. ET

Ginkgo Bioworks Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
DNA -67.59% -94%
S&P +26.17% +90.26% +13.73% +27%

Ginkgo Bioworks Company Info

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

News & Analysis

The Fool has written over 100 articles on Ginkgo Bioworks.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.